1. Postmarketing adverse event reporting for medical products and dietary supplements during a pandemic Publication: Silver Spring, MD : Office of Counterterrorism and Emerging Threats, May 2020 Subject(s): Dietary Supplements -- adverse effectsDrug-Related Side Effects and Adverse ReactionsEquipment Design -- adverse effectsEquipment SafetyProduct Surveillance, PostmarketingUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
